Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Dialysis patients get tailored diet advice to fight dangerous phosphate buildup

NCT ID NCT07180069

Disease control Sponsor: Kufa University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether personalized diet education could help hemodialysis patients lower high blood phosphate levels, a common and risky condition. Two hundred adults on dialysis were split into two groups: one received standard care, the other added targeted counseling on low-phosphate foods. The goal was to see if the extra education led to greater phosphate reduction over 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
diet education
What this could lead to
If successful, this approach could provide a simple, low-cost way to help dialysis patients better manage phosphate levels and reduce complications.
What could go wrong
This is a small, completed study. Diet changes can be hard to stick with, and results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

200 people

The number who actually took part.

Started

Oct 2024

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Males and females aged 18-60 years * Stage 5 CKD patients on hemodialysis * Receiving ≥2 weekly dialysis sessions for ≥2 months * Written informed consent provided * Ability (patient/caregiver) to read, write, and speak Arabic Exclusion Criteria: * Age \<18 or \>60 * Receiving \<2 dialysis sessions per week or \<2 months duration * Refusal or inability to provide consent * Severe mental illness or cognitive impairment * Acute illness, infection, or hospitalization at enrollment * Malabsorption conditions or prior GI surgery * Noncompliance with medication or dialysis regimen

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease 5D are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

end stage renal failure hyperphosphatemia phosphorus metabolism disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease 5D Diet therapy Hyperphosphataemia Phosphorus

Contacts and locations

Locations

  • University of kufa

    Najaf, 24001, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.